These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 436860)

  • 1. Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
    Peters JG
    Eur Neurol; 1979; 18(1):15-8. PubMed ID: 436860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid amine metabolites in acute schizophrenia.
    Post RM; Fink E; Carpenter WT; Goodwin FK
    Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
    Jeste DV; Doongaji DR; Linnoila M
    Br J Psychiatry; 1984 Feb; 144():177-80. PubMed ID: 6200172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
    Chase TN; Gordon EK; Ng LK
    J Neurochem; 1973 Sep; 21(3):581-7. PubMed ID: 4270247
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated CSF serotonin and dopamine metabolite levels in overweight subjects.
    Markianos M; Evangelopoulos ME; Koutsis G; Sfagos C
    Obesity (Silver Spring); 2013 Jun; 21(6):1139-42. PubMed ID: 23670875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine-serotonin relationship in clozapine response.
    Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
    Brashear A; Butler IJ; Hyland K; Farlow MR; Dobyns WB
    Ann Neurol; 1998 Apr; 43(4):521-6. PubMed ID: 9546335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.
    Shaywitz BA; Cohen DJ; Leckman JF; Young JG; Bowers MB
    Dev Med Child Neurol; 1980 Dec; 22(6):748-54. PubMed ID: 6161049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine compounds in cerebrospinal fluid of healthy subjects punctured without preceding strict bed rest: a pilot study.
    Eklundh T; Gunnarsson T; Nordin C
    Neuropsychobiology; 2001 Jan; 43(1):5-10. PubMed ID: 11150891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M; Ninan PT; Scheinin M; Waters RN; Chang WH; Bartko J; van Kammen DP
    Arch Gen Psychiatry; 1983 Dec; 40(12):1290-4. PubMed ID: 6197036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.
    van Kammen DP; Peters J; Yao J; van Kammen WB; Neylan T; Shaw D; Linnoila M
    Arch Gen Psychiatry; 1990 Feb; 47(2):161-8. PubMed ID: 1689140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic and dopaminergic metabolites in cerebrospinal fluid of epileptics.
    Mohan A; Nag D; Misra RN; Gujrati VR; Shanker K; Doval DC; Saxena RC; Bhargava KP
    Pharmazie; 1982 Nov; 37(11):803. PubMed ID: 6187028
    [No Abstract]   [Full Text] [Related]  

  • 15. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
    Bagdy G; Perényi A; Frecska E; Révai K; Papp Z; Fekete MI; Arató M
    Psychopharmacology (Berl); 1985; 85(1):62-4. PubMed ID: 2580329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free and conjugated amines in human lumbar cerebrospinal fluid.
    Tyce GM; Rorie DK; Byer DE; Danielson DR
    J Neurochem; 1985 Jan; 44(1):322-4. PubMed ID: 2578061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid.
    Major LJ; Murphy DL; Lipper S; Gordon E
    J Neurochem; 1979 Jan; 32(1):229-31. PubMed ID: 759576
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation of monoamines and their metabolite contents in the cerebrospinal fluid of conscious rats.
    Wada Y; Egashira T; Takayama F; Yamanaka Y; Takada K; Takeda H; Matsumiya T
    Jpn J Pharmacol; 1998 Oct; 78(2):237-40. PubMed ID: 9829629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between central monoaminergic systems: dopamine-serotonin.
    Roccatagliata G; Albano C; Cocito L; Maffini M
    J Neurol Neurosurg Psychiatry; 1979 Dec; 42(12):1159-62. PubMed ID: 160445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.